ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how our rules link it today.

9 links0 made here, not in the record10 judgments1 judge (our rules as one)2 record changes seen
Our rulesRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06598943A Study of Eltrekibart andMirikizumab in AdultPatients With Moderately toSeverely Active UlcerativeColitisEli Lilly and CompanyPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 30 · ClinicalTrials.gov record · Version of 2026-09-30Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Version of 2026-10-07CONDITIONSColitis, UlcerativeThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionGastrointestinal DiseasesThe registry's MeSH filing›Nov 14 · Our condition-kind rule · General: a category, not a diseaseGeneral: a category, not a diseaseInflammatory Bowel DiseasesThe registry's MeSH filing›Nov 14 · Our condition-kind rule · General: a category, not a diseaseGeneral: a category, not a diseaseDigestive System DiseasesThe registry's MeSH filing›Nov 14 · Our condition-kind rule · General: a category, not a diseaseGeneral: a category, not a diseaseColonic DiseasesThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Wider: a narrower term is filedWider: a narrower term is filedIntestinal DiseasesThe registry's MeSH filing›Nov 14 · Our condition-kind rule · General: a category, not a diseaseGeneral: a category, not a diseaseColitisThe registry's MeSH filing›Nov 14 · Our condition-kind rule · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSEltrekibartIntervention entry›As of now · Our role rule · TestedTestedMirikizumabIntervention entry›As of now · Our role rule · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Colitis, Ulcerative

From the registry record2 judgments on this link
Kind of condition link, from the registry to what was judged
RegistryColitis, Ulcerative, as filedthe registry files the study under it
→judged
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Sep 30The record itselfClinicalTrials.gov recordVersion of 2026-09-30Record change
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Nov 14Colitis, UlcerativeOur condition-kind ruleFinest filed termCurrent
Nov 14Gastrointestinal DiseasesOur condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Inflammatory Bowel DiseasesOur condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Digestive System DiseasesOur condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Colonic DiseasesOur condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Intestinal DiseasesOur condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14ColitisOur condition-kind ruleGeneral: a category, not a diseaseCurrent
As of nowColitis, UlcerativeOur main-condition rule (R9)Main conditionCurrent
As of nowEltrekibartOur role ruleTestedCurrent
As of nowMirikizumabOur role ruleBackgroundCurrent